Dysregulation of immunoglobulins and complement proteins in diabetic foot infections

Authors

  • Bashir Abdrhman Bashir Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia University, Port Sudan, Sudan

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261317

Keywords:

Diabetic foot infection, Immunoglobulin, Complement, HbA1c, Fasting blood sugar, Sudan

Abstract

Background: Diabetic foot infections (DFIs) continue to be a substantial contributor to morbidity, disability, and limb loss in resource-limited nations. Hyperglycemia is associated with impaired wound healing; however, the relationship between immune dysregulation and metabolic glitches in diabetic foot infections remains imperfectly characterized.

Methods: This cross-sectional analytical investigation recruited 55 patients with diabetic foot infections from a specialist diabetes care center in Eastern Sudan (2024–2025). Clinical factors, ulcer intensity (SINBAD score), fasting blood sugar (FBS), and glycated hemoglobin (HbA1c) were recorded. Plasma immunoglobulins (IgA, IgG, IgM) and complement (C3,C4) levels were measured and compared with reference values. Associations among immunological markers, glycemic indices, and ulcer intensity were analyzed using chi-square tests, correlation analyses, and regression models.

Results: The study consisted of 60% males and 40% females, with a mean age of 50.4±16.0 years and an average diabetes duration of 10.3±6.9 years. The majority exhibited advanced ulceration, with 52.7% receiving a SINBAD score of 6. The mean FBS and HbA1c levels were 191.0±71.9 mg/dl and 9.12±2.25%, respectively. Relative to reference values, IgA, C3, and C4 exhibited elevation (P<0.001), whereas IgM was reduced (P<0.001). Low IgM showed a linkage with increased HbA1c (P=0.030), whereas C3 was linked to FBS (P=0.049).

Conclusions: DFIs in Sudanese patients are accompanied by immune dysregulation, reduced IgM, and persistent complement signaling, linked to hyperglycemia. Assessing immunological markers alongside glycemic indices may expand the practical utility of prognostic evaluation in resource-limited settings.

References

Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review. JAMA. 2023;330(1):62-75.

Swaminathan N, Awuah WA, Bharadwaj HR, Roy S, Ferreira T, Adebusoye FT, et al. Early intervention and care for Diabetic Foot Ulcers in Low and Middle Income Countries: Addressing challenges and exploring future strategies: A narrative review. Health Sci Rep. 2024;7(5):e2075.

Dawi J, Tumanyan K, Tomas K, Misakyan Y, Gargaloyan A, Gonzalez E, et al. Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines. 2025;13(5):1076.

Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442-9.

Fejfarová V, Jirkovská A, Dubský M, Game F, Vydláková J, Sekerková A, et al. An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens. J Diabetes Res. 2016;2016:2356870.

Kheiralla ZM, Maklad SS, Ashour SM, El-Sayed Moustafa E. Association of complement C3 and interleukin-1 with foot infections in diabetic patients. Eur J Microbiol Immunol (Bp). 2012;2(3):220-30.

Ajjan RA, Schroeder V. Role of complement in diabetes. Mol Immunol. 2019;114:270-7.

Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67(7):1168-80.

American Diabetes Association Professional Practice Committee. Summary of Revisions: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1):S6-13.

Fejfarová V, Jirkovská A, Dubský M, Game F, Vydláková J, Sekerková A, et al. An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens. J Diabetes Res. 2016;2016:2356870.

Costantini E, Carlin M, Porta M, Brizzi MF. Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence. Acta Diabetol. 2021;58(9):1139-51.

Hui W, Yaping Y, Liqing G, Zhigang M, Peng Yinbo, Jing W. Study on the correlation between SINBAD system score and wound pH value in diabetic foot sarcopenia. J Tissue Viability. 2025;34(3):100915.

Dasari N, Jiang A, Skochdopole A, Chung J, Reece

EM, Vorstenbosch J, et al. Updates in Diabetic Wound Healing, Inflammation, and Scarring. Semin Plast Surg. 2021;35(3):153-8.

Downloads

Published

2026-04-29

How to Cite

Abdrhman Bashir, B. (2026). Dysregulation of immunoglobulins and complement proteins in diabetic foot infections. International Journal of Research in Medical Sciences, 14(5), 1837–1844. https://doi.org/10.18203/2320-6012.ijrms20261317

Issue

Section

Original Research Articles